Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.41 |
| ▸ | CA1 | P00915 | 3/20 | 0.41 |
| ▸ | FAAH | O00519 | 5/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | CNR1 | P21554 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.36 |
| ▸ | CTSK | P43235 | 1/20 | 0.36 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28942348 | 0.86 | CA1 (0.40) | CA2CA1FAAHLMNATSHR | |
| SCHEMBL28014256 | 0.85 | SLC15A1 (0.43) | CA2CA1FAAHLMNATSHR | |
| SCHEMBL27923447 | 0.84 | CA2 (0.41) | CA2CA1LMNATSHRCYP3A4 | |
| SCHEMBL27737209 | 0.84 | CA2 (0.41) | CA2CA1FAAHTSHRCYP3A4 | |
| Acetone SCHEMBL27686377 | 0.83 | FAAH (0.38) | CA2CA1FAAHLMNATSHR | |
| Hydrochloric Acid SCHEMBL28481819 | 0.83 | SLC15A1 (0.42) | CA2CA1FAAHLMNATSHR | |
| SCHEMBL27193080 | 0.82 | DPP7 (0.43) | CA2CA1FAAHLMNATSHR | |
| SCHEMBL28254027 | 0.82 | SLC15A1 (0.38) | CA2CA1FAAHLMNAMAPT | |
| SCHEMBL27576843 | 0.82 | FAAH (0.45) | CA2CA1FAAHLMNATSHR | |
| SCHEMBL7207177 | 0.81 | CA2 (0.41) | CA2CA1FAAHLMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106083839-B | A kind of preparation method of Dasatinib compound | 山东罗欣药业集团恒欣药业有限公司 | 2019-02-15 | — | — | CN | claimed |
| CN-106083839-A | A kind of preparation method of Dasatinib compound | 山东罗欣药业集团股份有限公司 | 2016-11-09 | — | — | CN | claimed |
| CN-102816175-B | A kind of heterocycle pyridine compounds, its intermediate, preparation method and purposes | SHANGHAI HUILUN TECHNOLOGY CO., LTD. (CN) | 2015-12-16 | — | — | CN | claimed |
| CN-112105600-B | Calixarene compound, curable composition, and cured product | DIC株式会社 | 2023-08-25 | — | — | CN | disclosed |
| CN-106083839-B | A kind of preparation method of Dasatinib compound | 山东罗欣药业集团恒欣药业有限公司 | 2019-02-15 | — | — | CN | disclosed |
| CN-106083839-B | A kind of preparation method of Dasatinib compound | 山东罗欣药业集团恒欣药业有限公司 | 2019-02-15 | — | — | CN | disclosed |
| CN-105859923-B | Olefin polymerization catalyst component, preparation method thereof and catalyst thereof | 中国石油天然气股份有限公司 | 2018-07-13 | — | — | CN | disclosed |
| CN-104405354-B | A kind of improved thick oil thermal recovery method and device | 西南石油大学 | 2017-03-15 | — | — | CN | disclosed |
| CN-106083839-A | A kind of preparation method of Dasatinib compound | 山东罗欣药业集团股份有限公司 | 2016-11-09 | — | — | CN | disclosed |
| CN-106083839-A | A kind of preparation method of Dasatinib compound | 山东罗欣药业集团股份有限公司 | 2016-11-09 | — | — | CN | disclosed |
| CN-106083804-A | A kind of synthetic method of octatomic ring lactone compound | 扬州大学 | 2016-11-09 | — | — | CN | disclosed |
| CN-105859923-A | Olefin polymerization catalyst component, preparation method thereof and catalyst thereof | 中国石油天然气股份有限公司 | 2016-08-17 | — | — | CN | disclosed |
| CN-102816175-B | A kind of heterocycle pyridine compounds, its intermediate, preparation method and purposes | SHANGHAI HUILUN TECHNOLOGY CO., LTD. (CN) | 2015-12-16 | — | — | CN | disclosed |
| CN-104405354-A | Improved heavy oil thermal recovery method and device | UNIV SOUTHWEST PETROLEUM | 2015-03-11 | — | — | CN | disclosed |